AOD-9604
Synthetic hGH fragment 176-191 analogue for lipid metabolism research.
Description
Synthetic hGH fragment 176-191 analogue for lipid metabolism research.
AOD-9604 is a modified 16-amino acid fragment corresponding to the C-terminal region (residues 176-191) of human growth hormone, with a tyrosine substitution that enhances its lipolytic activity. Its mechanism of action involves stimulating lipolysis and inhibiting lipogenesis in adipose tissue through a pathway distinct from the GH receptor, meaning it does not promote IGF-1 elevation or the diabetogenic effects associated with full-length growth hormone. Research conducted at Monash University by Ng et al. (Obesity Research, 2000) demonstrated that AOD-9604 reduced body fat in obese Zucker rats without affecting glucose tolerance or inducing growth-promoting effects. A subsequent human clinical trial (Stier et al., 2013) examined oral formulations and found the compound was well-tolerated, though weight loss results were modest compared to injectable administration in preclinical models. AOD-9604 was granted GRAS (Generally Recognized As Safe) status by the FDA in 2014 for use as a food supplement ingredient, distinguishing it from most peptides in its regulatory profile. Compared to full-length hGH, AOD-9604 offers a more targeted approach to fat metabolism research without the broad anabolic and insulin-resistance concerns. Additional preclinical studies suggest potential applications in cartilage repair and osteoarthritis models. Store the lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C, using reconstituted material within 21 days. AOD-9604 is studied by metabolic research laboratories, sports science institutions, and orthopedic research groups investigating cartilage regeneration.
This product is supplied as a lyophilized powder and is intended for laboratory and research use only. Not for human consumption. Each vial contains 5mg of research-grade material.
Research Applications
- Lipolysis and fat metabolism studies
- Adipocyte size reduction research
- Glucose and insulin regulation
- Body composition optimization
Specifications
- Size
- 5mg
- Purity
- ≥98% (HPLC)
- Form
- Lyophilized Powder
Storage & Handling
- Long-term storage: -20°C in a sealed, light-protected container
- Short-term storage: 2-8°C (refrigerated) for up to 30 days
- Reconstituted: Store at 2-8°C and use within 30 days
- Avoid: Repeated freeze-thaw cycles, direct sunlight, and moisture exposure
- Reconstitution: Use bacteriostatic water or sterile water for injection
Frequently Asked Questions
What is AOD-9604 and how does it work?
What research has been done on AOD-9604?
How does AOD-9604 compare to HGH Fragment 176-191?
What is the recommended reconstitution protocol for AOD-9604?
What purity testing is performed on AOD-9604?
Related Products
GLP3-R (Retatrutide)
Triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors for advanced metabolic studies.
Cagrilintide
Long-acting synthetic amylin analogue for obesity and metabolic research.
Tesamorelin
Synthetic GHRH analogue studied for visceral fat reduction and metabolic health.
Research Use Only. This product is not intended for human consumption, therapeutic use, or diagnostic purposes. All peptides sold by Elyte Peptides are strictly for in-vitro research and laboratory use. By purchasing, you agree to use this product in compliance with all applicable laws and regulations.